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Fe65 Is Phosphorylated on Ser289 after UV-
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Newcastle University, Newcastle upon Tyne, NE2 4AA, United Kingdom
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Abstract
Fe65 undergoes a phosphatase-sensitive gel mobility shift after DNA damage, consistent
with protein phosphorylation. A recent study identified Ser228 as a specific site of phos-
phorylation, targeted by the ATM and ATR protein kinases, with phosphorylation inhibiting
the Fe65-dependent transcriptional activity of the amyloid precursor protein (APP). The
direct binding of Fe65 to APP not only regulates target gene expression, but also contrib-
utes to secretase-mediated processing of APP, producing cytoactive proteolytic frag-
ments including the APP intracellular domain (AICD) and cytotoxic amyloid β (Aβ)
peptides. Given that the accumulation of Aβ peptides in neural plaques is a pathological
feature of Alzheimer’s disease (AD), it is essential to understand the mechanisms control-
ling Aβ production. This will aid in the development of potential therapeutic agents that act
to limit the deleterious production of Aβ peptides. The Fe65-APP complex has transcrip-
tional activity and the complex is regulated by multiple post-translational modifications
and other protein binding partners. In the present study, we have identified Ser289 as a
novel site of UV-induced phosphorylation. Interestingly, this phosphorylation was medi-
ated by ATM, rather than ATR, and occurred independently of APP. Neither phosphoryla-
tion nor mutation of Ser289 affected the Fe65-APP interaction, though this was markedly
decreased after UV treatment, with a concomitant decrease in the protein levels of APP in
cells. Using mutagenesis, we demonstrated that Fe65 Ser289 phosphorylation did not
affect the transcriptional activity of the Fe65-APP complex, in contrast to the previously
described Ser228 site.
Introduction
Fe65 is an adaptor protein consisting of an N-terminal WW domain and two C-terminal
phosphotyrosine binding domains (PTB1 and PTB2) [1]. By direct binding, Fe65 regulates
the secretase-mediated processing of APP [2] and formation of multiple proteolytic APP
fragments, including a large extracellular fragment, the 40–42 amino acid Aβ peptide
(from the APP transmembrane region) and the APP intracellular domain (AICD). Aβ
has cytotoxic potential and is likely to play an important role in the neurodegenerative
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processes associated with AD [3]. AICD is thought to translocate to the nucleus, in a process
involving direct binding to the PTB2 domain of Fe65 [4,5], before this complex (with
other co-activator proteins) activates the expression of genes including APP itself, BACE1,
GSK3β, acetylcholinesterase, KAI1, WASF, BEST1 and TIP60[6–11]. Cao and Sudhof dem-
onstrated the transcriptional activity of AICD (and full length APP) by generating fusion
proteins with the GAL4 DNA binding domain. Only in the presence of overexpressed Fe65
did AICD-GAL4 or APP-GAL4 fusion proteins activate GAL4-dependent luciferase produc-
tion [12]. Given the cellular consequences of aberrant APP processing and the important
transcriptional role of APP/AICD, it is essential to understand mechanisms regulating these
processes, for example the identification and characterisation of Fe65 post translational
modifications.
Phosphorylation of both proteins contributes to the regulation of the Fe65-APP interac-
tion. For example, direct binding between the PTB2 domain of Fe65 and the YENPTY motif
of APP/AICD is impaired by phosphorylation of APP Thr668 [7,13]. Genetic manipulation of
the Fe65-APP interaction (e.g. by mutation of Thr668 or by overexpression/down-regulation
of Fe65) affects APP processing, with subsequent alterations in the levels of Aβ [13–16]. Muta-
tion of a conserved cysteine in the Fe65 PTB2 domain blocks the interaction of Fe65 with APP
and concomitantly abolishes the transcriptional activity of APP [[17,18] and data in the pres-
ent study]. In addition, transcription induced by the Fe65-APP complex is enhanced by inter-
action with the c-Abl protein kinase and subsequent phosphorylation on Fe65 Tyr547 (within
PTB2) [19].
As well as roles in the regulation of APP, Fe65 has additional roles in the cellular response
to DNA damage [20–22]. Fe65 knockout mice showed elevated levels of DNA damage after
exposure to etoposide or ionising radiation [20]. Mechanistically, these effects were caused (at
least in part) by inefficient recruitment of the histone acetyltransferase TIP60 to sites of DNA
double strand breaks (DSBs), inefficient histone H4 acetylation and defective chromatin relaxa-
tion (an essential part of DNA repair processes) [22]. Fe65 was also shown to undergo a rapid
phosphatase-sensitive gel mobility shift after DNA damage, consistent with protein phosphor-
ylation, though no specific sites were identified nor functionally characterised [20]. Protein
phosphorylation after DNA damage is orchestrated by the ATM (ataxia telangiectasia mutated)
and ATR (ataxia telangiectasia and Rad3-related) kinases. These kinases generally respond to
different forms of DNA damage, for example ATM is activated in the presence of DNA DSBs
(e.g. IR or etoposide), whereas ATR is activated by stretches of single-stranded DNA, generated
during the processing of various DNA adducts and cross-links [23,24]. Active ATM/ATR
phosphorylate multiple target proteins, with target sequences corresponding to serine or threo-
nine residues followed by a glutamine, often referred to as the ‘SQ/TQ’motif [25,26]. We have
recently identified Fe65 Ser228 as a novel DNA damage-induced phosphorylation site and
showed that blocking Ser228 phosphorylation (by introducing an alanine mutation) enhanced
Fe65-APP transcriptional activity [17]. This suggests that DNA damage-induced phosphoryla-
tion could contribute to the complex regulatory mechanisms involved in Fe65-APP function
and thus be relevant to AD.
This study aimed to further characterise the role of DNA damage-induced Fe65 phosphory-
lation in regulating the Fe65-APP interaction or Fe65-APP-mediated gene transcription. This
study identified Fe65 Ser289 as a novel site of UV-induced phosphorylation, targeted by the
ATM protein kinase. Neither phosphorylation nor mutation of Ser289 affected the Fe65-APP
interaction. In addition, mutation of Fe65 Ser289 to alanine (thus blocking phosphorylation)
did not affect the transcriptional activity of the Fe65-APP complex, in contrast to the previ-
ously described Ser228 site.
Fe65 Ser289 Phosphorylation
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Materials and Methods
Cell lines, chemicals and treatments
HEK293 cells were obtained from PHE Culture Collections and maintained as exponentially
growing cultures in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) and 2mM L-glutamine. The ATR inhibitor AZ20 and ATM inhibitor
KU55933 (Tocris) were prepared at 10mM in DMSO. Inhibitors were added to cells at at final
concentrations of 5μM (AZ20) and 10μM (KU55933) 45min prior to UV treatment, with
DMSO levels maintained at 0.1% (v/v). For UV treatment, the growth medium was removed
from cells, before plates were placed in a UV crosslinker (lids were removed from the culture
plates) and exposed to 4-40Jm2 UV, as indicated in individual figures.
Plasmids
For overexpression studies, human Fe65 with a C-terminal FLAG-Myc tag was obtained from
Origene (RC202003) and Fe65 sub-cloned into expression vectors with N-terminal GFP or
FLAG tags (PS100048 and PS100014, respectively, Origene). Specific mutants of Fe65 were
generated using the Quikchange II XL site directed mutagenesis kit (Agilent). Primer details
can be provided on request. For luciferase reporter gene assays, pMST-APP [provided by Prof
Kwok-Fai Lau (The Chinese University of Hong Kong), with the kind permission of Prof
Thomas Südhof (Stanford University School of Medicine, USA)], pFR-Luc (Agilent) and
pRL-TK (Promega) were used.
Immunoprecipitation, Western blotting and Antibodies
After the indicated treatments, cells were washed in cold PBS before lysis in NETN buffer
(50mM Tris pH 7.6, 150mMNaCl, 1mM EDTA and 0.5% NP-40). After incubation at 4C for
15 min, lysates were cleared by centrifugation and supernatants isolated. For immunoprecipita-
tion, cell lysates were incubated with either GFP-Trap (Chromotek, for the purification of
GFP-tagged proteins) or FLAG-M2 agarose beads (Sigma, for the purification of FLAG/FLAG-
tagged proteins) for 2 hours at 4C before washing three times in TBST (50mM Tris pH 7.6,
150mMNaCl and 0.2% Tween-20). For immunoprecipitation of endogenous Fe65, cell lysates
were incubated overnight with 4μl of Fe65 antibody (ab91650, Abcam). For lambda phospha-
tase treatment, beads were resuspended in 50μl of reaction buffer and 200U of lambda protein
phosphatase (P0753S, New England Biolabs) for 15 min at 30C before washing again in TBST.
Beads were resuspended in an equal volume of 2X LDS sample buffer (Life Technologies) con-
taining 2.5% 2-mercaptoethanol before heating at 95C for 5 min. Samples were analysed by
Western blotting using 4–12% bis-tris gels (Life Technologies) before transferring to nitrocellu-
lose using an iBlot machine (Life Technologies). Membranes were blocked in 2.5% BSA/TBST
for 1 hour prior to overnight incubation (4C) in blocking buffer containing the following pri-
mary antibodies: GFP (2956), APP (2452), phospho-S/T-Q (‘pATM/ATR motif’, 2851), CHK1
phospho-Ser317 (12302), GAPDH (2118), all from Cell Signalling Technology and FLAG
(F1804, Sigma). The primary antibody referred to as p-Fe65x in this study was raised against a
phosphopeptide encompassing the previously described Ser228 site. Characterisation of this
antibody revealed that mutation of Fe65 Ser228 reduced, but did not abolish, the DNA damage-
induced Western blot signal after p-Fe65x detection. We hypothesised that p-Fe65x was thus
recognising additional Fe65 phosphorylation sites and used this antibody and mutagenesis in
the present study to identify a new Fe65 phosphorylation site. After incubation with the rele-
vant HRP-conjugated secondary antibody, western blots were visualised using ECL Prime (GE
Healthcare) and images captured using a Syngene G:Box gel documentation system. When
Fe65 Ser289 Phosphorylation
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images were quantified, ImageJ software was used, with levels of p-Fe65x normalised to Fe65
levels in the corresponding immunoprecipitate. For statistical analysis, a paired t-test (two-
tailed) was used, with level of significance defined as: p< 0.05 (), p< 0.01 () and p< 0.001
(). All Western blot images are representative of at least three independent experiments.
GFPmicroscopy
For analysis of GFP-Fe65 and GFP-Fe65 S289A localisation, HEK293 cells were transfected
with the relevant plasmid using calcium phosphate. After 24h, cells were fixed on glass cover-
slips with 4% formaldehyde and stained with DAPI. Fluorescence images were captured using
a Zeiss Axioscope fluorescence microscope. Data are representative of at least three indepen-
dent experiments.
Luciferase Reporter Gene Assay
The APP-dependent luciferase assay has been described previously and was performed accord-
ing to our earlier study [12,17].
Results
Fe65 is phosphorylated on Ser289 after UV-induced DNA damage
As part of an earlier study, we identified Fe65 Ser228 as a DNA damage-induced site of phos-
phorylation using an anti-ATM/ATR motif antibody [raised against a library of peptides phos-
phorylated on Ser/Thr followed by Gln (SQ/TQ)–the ATM/ATR ‘consensus sequence’]. We
attempted to generate a phosphospecific antibody to Ser228 and tested the reactivity/specificity
of this antibody in immunoprecipitations. Throughout the manuscript, this antibody is
referred to as p-Fe65x. Cells were transfected with GFP-Fe65 or GFP-Fe65 S228A and Fe65
immunoprecipitated from untreated cells or UV-treated cells (to induce DNA damage). As
shown in Fig 1A and (1A in S1 Fig), immunoprecipitated GFP-Fe65 was detected by the
pATM/ATR motif antibody and the signal was markedly increased after DNA damage. This
signal was completely abolished by mutation of Ser228, consistent with our previously pub-
lished data. The same samples were analysed using the p-Fe65x antibody. Again, GFP-Fe65
was detected by this antibody and the signal was increased after DNA damage. However, when
Ser228 was mutated, the p-Fe65x signal was reduced but not completely abolished, and was still
increased after UV. This strongly suggests that p-Fe65x recognises Ser228, as well as additional
DNA damage-induced phosphorylation site(s). To confirm that p-Fe65x was binding other
phosphorylation sites in GFP-Fe65 S228A, immunoprecipitates were analysed in the presence
and absence of λ-phosphatase. As shown in Fig 1B, p-Fe65x detected GFP-Fe65 S228A and
the signal was increased after UV. Importantly, this signal was completely abolished when
GFP-Fe65 S228A immunoprecipitates were treated with λ-phosphatase. These data confirm
that p-Fe65x is recognising one or more additional UV-induced phosphorylation sites in
GFP-Fe65 S228A.
Given that the p-Fe65x antibody was raised against a peptide encompassing a phospho-SQ
motif, and the signal was increased after DNA damage, we hypothesised that another phos-
pho-SQ site was being recognised by this antibody. To help identify the specific SQ site (or
sites) being recognised by p-Fe65x, a series of Fe65 deletion mutants (Fig 1C) were immuno-
precipitated from UV-treated cells and tested for p-Fe65x reactivity. Importantly, each deletion
mutant also had Ser228 mutated to Ala, to prevent p-Fe65x recognising this site. As shown in
Fig 1D, Fe65 1–349 was detected by p-Fe65x but Fe65 1–280 and 1–220 were not (compare
lane 2 with lanes 3/4 in left hand panel). To confirm phosphorylation of Fe65 S228A 1–349, we
Fe65 Ser289 Phosphorylation
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Fig 1. Fe65 is phosphorylated on Ser289 after UV-induced DNA damage. (A) HEK293 cells were transfected with
GFP-Fe65 or GFP-Fe65 S228A for 24h before treatment with 40J/m2 UV for 2h. Cell extracts were subjected to GFP
immunoprecipitation and samples analysed byWestern blotting using the indicated antibodies. (B) HEK293 cells were
transfected with GFP-Fe65 S228A for 24h before treatment with 40J/m2 UV for 2h. After GFP immunoprecipitation,
each sample was split and half treated with lambda phosphatase for 15min at 30C, before western blot analysis with
Fe65 Ser289 Phosphorylation
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demonstrated that p-Fe65x signal was completely abolished by phosphatase treatment of UV-
treated GFP-Fe65 S228A 1–349 immunoprecipitates (1B in S1 Fig). This means that the phos-
phorylation site being detected by p-Fe65x is within the region 280–349. Next, a further series
of deletion mutants targeting this region were constructed, and immunoprecipitated from UV-
treated cells. As shown in Fig 1E, 1–295 was detected by p-Fe65x, whereas 1–280 was not.
Analysis of the Fe65 protein sequence showed that there was only one SQ site in this region—
Ser289. Therefore, Ser289 was mutated in GFP-Fe65 S228A to generate the S228A/S289A double
phosphomutant. These Fe65 variants were immunoprecipitated from UV-treated cells and
tested for reactivity with p-Fe65x. As shown in Fig 1F, p-Fe65x recognised GFP-Fe65 S228A
but this signal was totally lost when Ser289 was additionally mutated. This confirms that Ser289
is a novel site of phosphorylation (likely to be targeted by ATM/ATR due to SQ sequence) and
that the p-Fe65x antibody is able to detect both Ser228 and Ser289. Analysis of the sequence con-
text of these two phosphorylation sites reveals significant similarity, with an identical SQGS
sequence present in both (Fig 1G). This is likely to explain why p-Fe65x recognises both Ser228
and Ser289. To validate the mutagenesis data, it was important to show that the loss of p-Fe65x
reactivity in the S228A/S289A mutant was not simply due to a mutation-induced change in cel-
lular localisation. Previous studies have showed that Fe65 is present in both the cytoplasm and
nucleus (with ATM and ATR being predominantly nuclear). Using fluorescence microscopy, it
was demonstrated that mutation of Ser289 in GFP-Fe65 did not affect cellular localisation, with
Fe65 and S289A being present in both the cytoplasm and nucleus (Fig 1H). The localisation of
Fe65 is consistent with previously published data [27–29]. Together, these data confirm that
Fe65 Ser289 is a novel DNA damage-inducible phosphorylation site. Importantly, it was dem-
onstrated that p-Fe65x reacted with immunoprecipitated endogenous Fe65, with the western
blot signal markedly increased after UV (Fig 1I). This shows that endogenous Fe65 is phos-
phorylated after UV, likely on both Ser228 and Ser289.
To investigate the kinetics and dose response of Fe65 Ser289 phosphorylation after UV,
GFP-Fe65 S228A was transfected into cells. By using GFP-Fe65 S228A for these studies, it was
ensured that p-Fe65x was specifically binding only to Ser289 and thus data was specific for this
site. Cells were exposed to the indicated doses of UV for the indicated times and GFP-Fe65
S228A immunoprecipitated before Western blotting with p-Fe65x. As shown in Fig 2A/2B,
Fe65 Ser289 phosphorylation was increased as early as 15min after UV treatment (~2-fold) and
continued to increase up to 240min (~3-fold). In Fig 2C/2D, it was demonstrated that Fe65
Ser289 phosphorylation was increased after UV doses as low as 4J/m2 (1.5-fold), and continued
to increase up to 40J/m2 (~4.5-fold). These data confirm that Fe65 Ser289 is phosphorylated
after UV in a dose- and time-dependent manner.
To identify the kinase that is phosphorylating Fe65 Ser289, specific inhibitors were used.
Ser289 conforms to the SQ/TQ target site of the ATM/ATR protein kinases. Generally, ATR is
the major kinase activated after UV, though ATM can also contribute to UV-induced DNA
damage signalling. Cells were transfected with GFP-Fe65 S228A before treatment with either
DMSO, AZ20 (ATR inhibitor) or KU55933 (ATM inhibitor) followed by UV and analysis of
the indicated antibodies. (C) Schematic showing the panel of GFP-Fe65 S228A deletion mutants, which were
transfected into cells in (D) and (E) before UV-treatment (40J/m2 2h), GFP immunoprecipitation andWestern blotting
with the indicated antibodies. (F) GFP-Fe65 S228A or GFP-Fe65 S228A/S289A were transfected into HEK293 cells for
24h before treatment with 40J/m2 UV (2h). After GFP immunoprecipitation, samples were analysed byWestern blotting
with the indicated antibodies. (G) Alignment of the amino acid sequence surrounding Ser228 and Ser289. (H)
Fluorescence microscopy showing cellular localisation of GFP-Fe65 and GFP-Fe65 S289A. Images are representative
of at least three independent experiments. (I) Endogenous Fe65 was immunoprecipitated from untreated or UV-treated
cells and samples analysed byWestern blotting with the indicated antibodies. GST antibody was used in negative
control immunoprecipitations from UV-treated cells.
doi:10.1371/journal.pone.0155056.g001
Fe65 Ser289 Phosphorylation
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Fig 2. Time- and dose-dependent phosphorylation of Fe65 Ser289 after UV. (A) GFP-Fe65 S228A was transfected
into HEK293 cells 24 hrs prior to treatment with UV (40J/m2). Cells were incubated for 15, 120 and 240 minutes before
GFP immunoprecipitation andWestern blot analysis with the indicated antibodies. (B) Quantification of p-Fe65x signal in
(A) normalised to total GFP-Fe65 in corresponding immunoprecipitate. (C) GFP-Fe65 S228A was transfected into
HEK293 cells 24 hrs prior to treatment with 4, 8, 20 or 40 J/m2 UV for 2h. After GFP immunoprecipitation, samples were
Fe65 Ser289 Phosphorylation
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Fe65 Ser289 phosphorylation using p-Fe65x. As shown in Fig 2E and S2 Fig, Fe65 Ser289 phop-
shorylation was increased after UV. Interestingly, inhibition of ATR had no effect on this UV-
induced phosphorylation, whilst ATM inhibition significantly reduced Ser289 phosphorylation
(Fig 2E and 2F). To confirm the efficacy of the ATR inhibitor, the phosphorylation of a well-
characterised UV-induced ATR target site (CHK1 Ser317) was investigated in the cell extracts.
As shown in Fig 2E, CHK1 Ser317 phosphorylation was markedly increased after UV and
completely abolished by ATR inhibition, confirming that ATR was inhibited by AZ20.
Together, these data suggest that Fe65 Ser289 is phosphorylated after UV in an ATM-depen-
dent manner.
Fe65 interaction with APP is not required for Ser289 phosphorylation
Cells lacking Fe65 have increased sensitivity to DNA damage, which can be rescued by exoge-
nous expression of Fe65. However, expression of a variant of Fe65 that cannot bind APP, was
unable to rescue the phenotype of Fe65-deficient cells [22]. This suggests that the DNA damage
response roles of Fe65 depend (at least in part) upon its interaction with APP. We therefore
investigated whether the Fe65-APP interaction was required for DNA damage-induced phos-
phorylation of Fe65 Ser289. An Fe65 mutant that was unable to interact with APP was gener-
ated by mutating Cys652 to phenylalanine in the PTB2 domain of Fe65 (C652F). Cells were
then transfected with FLAG-Fe65 S228A or FLAG-Fe65 S228A/C652F before treatment with
UV, Fe65 purification and analysis of Ser289 phosphorylation using p-Fe65x. Again, perform-
ing all studies in a S228A mutant background ensured that results were specific to Ser289. As
shown in Fig 3 and S3 Fig, FLAG-Fe65 S228A clearly interacted with APP in untreated cells
and this interaction was abolished in the S228A/C652F mutant. Consistent with our previously
published data, there was a marked decrease in the Fe65-APP complex after UV, along with a
concomitant decrease in APP in the cell extracts. Experiments are in progress to determine
whether the loss of the Fe65-APP complex precedes the decrease in APP protein levels or vice
versa. With regards to Fe65 phosphorylation, the interaction with APP is clearly not required,
with no difference in UV-induced Ser289 phosphorylation in FLAG-Fe65 S228A or FLAG-Fe65
S228A/C652F (Fig 3, top panel).
Fe65 Ser289 phosphorylation does not regulate the Fe65-APP
interaction
The Fe65-APP interaction can be disrupted by APP Thr668 phosphorylation. To investigate
whether Fe65 Ser289 phosphorylation affected the interaction with APP, we compared the
interaction between FLAG-Fe65 or FLAG-Fe65 S289A and endogenous APP, before and
after UV-induced DNA damage. As shown in Fig 4 and S4 Fig, Fe65 interacted with APP in
untreated cells, with levels of the Fe65-APP complex being markedly reduced by UV treatment,
in agreement with our previously published data. Again, there was a concomitant decrease in
the protein levels of APP in cell extracts after UV. Mutation of Ser289 did not affect the interac-
tion with APP in untreated cells, or after UV treatment. These data show that Ser289 phosphor-
ylation does not regulate the Fe65-APP interaction and is not involved in the UV-induced
analysed byWestern blotting with the indicated antibodies. (D) Data in (C) was quantified as in (B). (E) HEK293 cells
were transfected with FLAG-Fe65 S228A for 24h before treatment with DMSO, 5μMAZ20 or 10μMKU55933 for 45min,
followed by 40J/m2 UV for 2h and GFP immunoprecipitation. Samples were analysed byWestern blotting with the
indicated antibodies and p-Fe65 quantified relative to FLAG-Fe65 in corresponding immunoprecipitates. Data is the
mean and standard deviation from three independent experiments (F) Statistical significance was investigated using a
two-tailed paired t-test (* p<0.05). Images are representative of at least three independent experiments.
doi:10.1371/journal.pone.0155056.g002
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decrease in the Fe65-APP complex (or the concomitant decrease in APP levels in the cell
extracts after UV).
Mutation of Fe65 Ser289 has no effect on Fe65-APP-mediated gene
transcription
Previous studies have demonstrated that Fe65 markedly enhanced APP-mediated gene tran-
scription. To investigate the potential role of Fe65 Ser289 phosphorylation in Fe65-APP tran-
scriptional activity, a luciferase-based reporter gene assay was used in HEK293 cells. This
system has been used in multiple studies and has revealed a complex regulatory network con-
trolling Fe65-APP mediated transcription [12,17,19,30]. To validate the system in the present
study, we showed that pMST-APP (full-length APP fused to the GAL4 DNA binding domain)
resulted in little luciferase activity (firefly luciferase under the control of a GAL4 binding site,
Fig 5A). Importantly, expression of FLAG-Fe65 markedly increased APP transcriptional activ-
ity (~14-fold, whereas FLAG-Fe65 C652F, unable to bind APP, did not (Fig 5A). Western blot-
ting confirmed expression of both FLAG-Fe65 and FLAG-Fe65 C652F (Fig 5B). A previous
study has demonstrated that Fe65 expressed without pMST-APP does not result in luciferase
transcription in this system [30]. Having validated the luciferase assay, the effect of mutating
Ser289 in Fe65 was investigated. As shown in Fig 5C/5D, FLAG-Fe65 and FLAG-Fe65 S289A
Fig 3. Fe65 Ser289 phosphorylation occurs independently of the Fe65-APP interaction. HEK293 cells
were transfected with FLAG-Fe65 S228A or FLAG-Fe65 S228A/C652F for 24h before treatment with 40J/m2
UV for 2h. Cell extracts were subjected to FLAG immunoprecipitation beforeWestern blot analysis with the
indicated antibodies. Images are representative of at least three independent experiments.
doi:10.1371/journal.pone.0155056.g003
Fe65 Ser289 Phosphorylation
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were both able to activate APP transcriptional activity to the same extent. These studies suggest
that Fe65 Ser289 phosphorylation is not involved in regulating the transcriptional activity of the
Fe65-APP complex.
To confirm the reproducibility of data, repeats of relevant studies are included in the supple-
mentary material (S1–S4 Figs).
Discussion
In the present study, we identified Fe65 Ser289 as a novel site of UV-induced phosphorylation.
Phosphorylation increased in a dose- and time-dependent manner and was found to be tar-
geted by ATM, rather than ATR, after UV in an APP-independent manner. Mutation of Ser289
to Ala did not affect the Fe65-APP interaction nor the Fe65-APP transcriptional activity. These
findings are in contrast to the Fe65 Ser228 site that we previously identified, which we found to
be targeted by ATR after UV and contributed to the regulation of Fe65-APP transcriptional
activity.
Previous studies demonstrated that Fe65 displayed a phosphatase-sensitive gel mobility
shift after DNA damage [20]. Our recent research has aimed to identify these specific sites,
with Ser228 described recently and Ser289 identified in the present study [17]. These sites both
conform to the SQ/TQ consensus sequence for the ATM/ATR kinases and are relatively close
together, in terms of the amino acid sequence of Fe65. In total, Fe65 contains 10 SQ/TQ sites,
and 4 of these are found between residues 228 and 300, a region including the functionally
Fig 4. Fe65 Ser289 phosphorylation does not regulate the Fe65-APP interaction. HEK293 cells were
transfected with FLAG-Fe65 or FLAG-Fe65 S289A for 24h before treatment with 40J/m2 UV for 2h. Cell
extracts were subjected to FLAG immunoprecipitation before western blot analysis with the indicated
antibodies. Images are representative of at least three independent experiments.
doi:10.1371/journal.pone.0155056.g004
Fe65 Ser289 Phosphorylation
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Fig 5. Fe65 Ser289 does not regulate Fe65-APP transcriptional activity. (A) HEK293 cells were transfected
with the indicated plasmids for 24h prior to cell lysis and measurement of both firefly and renilla luciferase
activities. To normalise for transfection efficiency the ratio of firefly/renilla luciferase values were calculated
(each sample in triplicate). (B) The cellular samples used for the luciferase assay in (A) were analysed by
Western blotting to confirm equal expression of both FLAG-Fe65 and FLAG-Fe65 C652F. (C) and (D) HEK293
Fe65 Ser289 Phosphorylation
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important WW domain, which mediates Fe65 interactions with several binding partners.
Often, ATM and ATR have been found to target ‘clusters’ of SQ/TQ sites, with multiple phos-
phorylation sites identified in close sequence proximity [26]. Given our recent data, it is tempt-
ing to speculate that ATM/ATR target a cluster of SQ/TQ sites within Fe65 228–300, and this
in turn could regulate WW domain-dependent interactions with several proteins including
Mena, c-abl and the nucleosome assembly factor SET [10,31,32]. Immunoprecipitation studies
with relevant phosphomutants are in progress to test this hypothesis. Interestingly, whilst both
of these sites were phosphorylated after UV, they appear to be differentially regulated, with
Ser228 being ATR-dependent and Ser289 being ATM-dependent. To gain further insight into
this differential regulation, it will be important to compare the phosphorylation kinetics of
each site after different forms of DNA damage and investigate the kinase involved.
Fe65 knockout (KO) mouse embryonic fibroblasts (MEFs) showed elevated levels of DNA
damage after exposure to etoposide or ionising radiation, caused (at least in part) by inefficient
recruitment of the histone acetyltransferase TIP60 to sites of DNA double strand breaks
(DSBs), inefficient histone H4 acetylation and defective chromatin relaxation (an essential part
of DNA repair processes) [20,22]. Whilst exogenous expression of Fe65 could correct the phe-
notype of Fe65 KOMEFs, a mutant version that was unable to interact with APP could not.
This suggests that the interaction of Fe65 with APP is involved in the DNA damage response
roles of Fe65, possibly involving a conformational change of Fe65. Cao and Suddhof suggested
that free Fe65 adopts a ‘closed’ conformation, due to intramolecular interactions between the
WW and PTB domains [12]. Upon binding to APP, these interactions are disrupted and Fe65
converts to an ‘open’ conformation, which is able to bind chromatin and initiate remodelling.
In support of this, it was demonstrated that wild-type Fe65 could bind chromatin, whereas a
non APP-interacting mutant version of Fe65 could not [22]. Our data has shown that UV-
induced phosphorylation of Fe65 on Ser228 and Ser289 occurs independently of the APP inter-
action. Assuming that the above model is correct, this suggests that the ‘closed’ conformation
of Fe65 can still be targeted by the ATM/ATR kinases and that the phosphorylation occurs
independently of chromatin interaction. Interestingly, as well as multiple studies demonstrat-
ing that Fe65 contributes to the cellular DNA damage response, recent publications have impli-
cated Fe65 in breast cancer biology. More specifically, Sun et al (2014) provided some evidence
that Fe65 expression is increased in breast cancer cell lines and that Fe65 was able to act as an
activator of estrogen receptor-α (ERα), promoting cell growth [33]. Interestingly, Fe65 overex-
pression also decreased the antagonistic activity of tamoxifen, identifying Fe65 as a potential
novel factor in mediating tamoxifen resistance in breast cancer. The same research group have
recently demonstrated that Fe65 can suppress cell migration and invasion in ERα-negative
breast cancer cells by recruiting Tip60 to cortactin and stimulating its acetylation [34]. Given
the role of Fe65 in the DNA damage response and the recent studies mechanistically linking
Fe65 to breast cancer, it will be important to elucidate the functional significance of DNA dam-
age-induced phosphorylation of Fe65 (on both Ser228 and Ser289) in these particular research
areas. Studies are in progress to functionally characterise these new phosphorylation sites in
response to DNA damage by expressing phosphomutant versions of each in Fe65-deficient
cells.
cells were transfected with the indicated plasmids for 24h prior to luciferase assays andWestern blot analysis as
in (A) and (B). Data is the mean and standard deviation of triplicate samples and is representative of at least
three independent experiments. The significance of the observed changes in relative luciferase activity were
investigated using a paired t-test (two-tailed). Levels of significance were defined as follows: p < 0.05 (*),
p < 0.01 (**) and p < 0.001 (***).
doi:10.1371/journal.pone.0155056.g005
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Mutation of Ser289 to Ala did not affect the Fe65-APP interaction or the transcriptional
activity of this complex. On the contrary, we previously demonstrated using both phospho-
blocking and phopshomimetic mutations, that Fe65 Ser228 phosphorylation inhibited
Fe65-APP transcriptional activity [17]. In addition, we have repeatedly shown that DNA dam-
age caused a loss of the Fe65-APP complex, with a concomitant decrease in the protein levels
of APP. It is unclear whether UV-induced loss of the Fe65-APP complex precedes APP protein
depletion or vice versa. Previous studies showed down-regulation of APP in response to both
UV and camptothecin, with Cuesta et al (2009) suggesting a p53-dependent reduction in the
transcription of APP, whereas Almenar-Queralt (2014) showed that the decrease in APP was
due to secretase-mediated cleavage [7,23,35]. Our unpublished studies demonstrate that the
decrease in both the Fe65-APP complex and APP in cell extracts occurs within 30 minutes
after UV, suggesting that the effect is not caused by altered transcription. The mechanisms
mediating APP depletion after DNA damage, and whether Fe65 contributes to this effect,
require further study. It will also be important to understand the precise fate of APP after dif-
ferent forms of DNA damage. In particular, if APP loss is secretase-dependent, this could have
important consequences in terms of Aβ production and thus be directly relevant to AD aetiol-
ogy. In addition, loss of the Fe65-APP complex after DNA damage is likely to have a significant
impact on the transcription of APP target genes. It has been proposed that the cytotoxicity of
Aβ is mediated (at least in part) by inducing mitochondrial dysfunction and increased oxida-
tive stress. Among multiple cellular targets, reactive oxygen species can cause DNA damage
and we are therefore currently investigating whether oxidative stress and/or Aβ peptides affect
Fe65 phosphorylation and cellular levels of the Fe65-APP complex.
Given the roles of Fe65 in Alzheimer’s biology and DNA damage response pathways, it is
important to fully elucidate the mechanisms regulating Fe65 and how these impact on the
function of Fe65 and Fe65-binding partners within the cell. This study has identified Ser289 as a
novel site of ATM-dependent phosphorylation after UV-induced DNA damage. Whilst this
site appears to have no role in mediating the Fe65-APP interaction or transcriptional activity
of this complex, it will be important to investigate how this site contributes to the DNA damage
response roles of Fe65.
Supporting Information
S1 Fig. P-Fe65x detects Ser228 and at least one other phosphorylation site. (A) HEK293 cells
were transfected with GFP-Fe65 or GFP-Fe65 S228A for 24h before treatment with 40J/m2 UV
for 2h. Cell extracts were subjected to GFP immunoprecipitation and samples analysed by
Western blotting using the indicated antibodies. Please note, we have previously published the
data in S1A (see Jowsey and Blain, 2015). (B) HEK293 cells were transfected with GFP-Fe65
S228A 1–349 for 24h before treatment with 40J/m2 UV for 2h. After GFP immunoprecipita-
tion, each sample was split and half treated with lambda phosphatase for 15min at 30C, before
western blot analysis with the indicated antibodies.
(PDF)
S2 Fig. ATM-medicated phosphorylation of Fe65 Ser289 after UV.HEK293 cells were trans-
fected with FLAG-Fe65 S228A for 24h before treatment with DMSO, 5μMAZ20 or 10μM
KU55933 for 45min, followed by 40J/m2 UV for 2h and GFP immunoprecipitation. Samples
were analysed by Western blotting with the indicated antibodies.
(PDF)
S3 Fig. Fe65 Ser289 phosphorylation occurs independently of the Fe65-APP interaction.
HEK293 cells were transfected with FLAG-Fe65 S228A or FLAG-Fe65 S228A/C652F for 24h
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before treatment with 40J/m2 UV for 2h. Cell extracts were subjected to FLAG immunoprecipi-
tation before Western blot analysis with the indicated antibodies.
(PDF)
S4 Fig. Fe65 Ser289 phosphorylation does not regulate the Fe65-APP interaction. HEK293
cells were transfected with FLAG-Fe65 or FLAG-Fe65 S289A for 24h before treatment with
40J/m2 UV for 2h. Cell extracts were subjected to FLAG immunoprecipitation before western
blot analysis with the indicated antibodies.
(PDF)
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